The Senate of the Republic of Colombia anticipates approving the Atoms for Life bill before the end of the legislative session in June 2026. The Senate’s First Committee endorsed the bill on May 5th after completing its penultimate legislative debate. This bill establishes the regulatory framework for the peaceful use of atomic technology and creates the National Nuclear Safety Agency (ANSN).
The National Government seeks to guarantee autonomy in the production of radiopharmaceuticals for the treatment of cancer and chronic diseases.
Maria del Mar Pizarro, a member of the House of Representatives and author of the bill, described the initiative as a giant step toward saving thousands of patients who depend on imported supplies.
The proposal addresses the need to reduce high costs and logistical delays that hinder timely cancer diagnoses. The congresswoman added that the lack of clear regulations currently impedes the development of advanced technical infrastructure.
Legislative risks and the pre-election environment
The Senate plenary faces a potential delay in the final discussion due to the electoral calendar. With elections approaching, political divisions could prevent the consensus required for the bill’s final approval. Supporters are working to secure enough votes before the focus shifts to regional campaigns, which could sideline the legislation. If the Senate does not pass the bill before the session ends, it would expire, requiring a new legislative process in the next period.
#ConDignidadCumplimos 💚 Celebramos la aprobación por unanimidad del proyecto de #LeyNuclear que crea la Agencia Nacional de Seguridad Nuclear (ANSN) en la Comisión Primera del Senado, un avance decisivo para fortalecer la investigación aplicada, la innovación y el uso… pic.twitter.com/AUrM1fWNpQ
— MinCiencias Colombia (@MincienciasCo) May 5, 2026
The text defines the responsibilities of state entities and private operators within a unified monitoring system. The articles stipulate that the State will assume the administration of sensitive materials throughout the national territory. The framework aims to block the diversion of nuclear energy toward illicit activities.
Structure of the National Nuclear Safety Agency
The National Nuclear Safety Agency (ANSN) will operate as an independent technical entity attached to the Ministry of Mines and Energy and will assume the control and licensing functions currently carried out by various state agencies in a fragmented manner.
The regulations explicitly prohibit the manufacture, possession, or transit of nuclear weapons on national soil. The budget for the operation of this agency is estimated at 48 billion pesos (US$12 million).
The agency must ensure that all future facilities comply with the physical and technological safety protocols required by global organizations. ANSN inspectors will conduct periodic checks at facilities where staff handle ionizing radiation sources.
The administrative structure will streamline the procedures for opening new private and public nuclear medicine centers. The law grants the agency immediate sanctioning powers for non-compliance with current radiation protection regulations.
Projected national production of radiopharmaceuticals
The Colombian Geological Survey (SGC) is set to spearhead domestic radioisotope production via Bogota’s IAN-R1 nuclear research reactor. The SGC reactor will transform stable materials into radioactive isotopes needed for public health once the SGC completes the necessary technical upgrades.
Local production will focus on elements such as iodine-131 and technetium-99m, medications with a short shelf life that require immediate transport logistics. The projected savings from import substitution will allow for expanded medical service coverage in the country’s outlying regions.
Benefits and functioning of nuclear medicine
Nuclear medicine uses radioactive substances in minute doses to precisely visualize the functioning of internal organs. These radiopharmaceuticals emit signals that scanning equipment transforms into detailed images for the medical team.
This technology identifies cellular abnormalities before physical symptoms become apparent. The precision of the method facilitates the design of personalized treatments for patients with cardiac, oncological, or neurological conditions.
Targeted internal radiation therapy allows for the selective destruction of tumors without affecting surrounding healthy tissue. This therapeutic approach reduces side effects and improves patients’ quality of life. Enhanced regulatory stability should draw foreign capital into the development of state-of-the-art biotechnology labs. Scientific sovereignty in this field positions Colombia as a leader in the civilian use of nuclear technology in South America.